SALT LAKE CITY, Jan. 8, 2015 /PRNewswire/ -- Ryan Ashton, co-founder and CEO of Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, will speak at 2:20 p.m. PST, Jan. 13, at the 8th Annual OneMedForum 2015 at the Marriott Marquis Hotel in San Francisco. Management will also be available for investor meetings on Jan. 13.
The Company's presentation from the event will be available at http://client.irwebkit.com/gbscience/presentations on Jan. 13, 2015 and will be archived for 90 days.
About Great Basin Scientific
Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company's website at www.gbscience.com.
Martina Schwarzkopf, Ph.D.
Russo Partners, LLC
Investor Relations Contact:
SOURCE Great Basin Scientific, Inc.